These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 36967927)

  • 1. The multi-omics analysis identifies a novel cuproptosis-anoikis-related gene signature in prognosis and immune infiltration characterization of lung adenocarcinoma.
    Jiang G; Song C; Wang X; Xu Y; Li H; He Z; Cai Y; Zheng M; Mao W
    Heliyon; 2023 Mar; 9(3):e14091. PubMed ID: 36967927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and Validation of Anoikis-Related Signatures for Predicting Prognosis in Lung Adenocarcinoma with Machine Learning.
    Wang Q; Sun N; Zhang M
    Int J Gen Med; 2023; 16():1833-1844. PubMed ID: 37213475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of a novel cuproptosis-related stemness signature to predict prognosis and immune landscape in lung adenocarcinoma by integrating single-cell and bulk RNA-sequencing.
    Yang J; Liu K; Yang L; Ji J; Qin J; Deng H; Wang Z
    Front Immunol; 2023; 14():1174762. PubMed ID: 37287976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A cuproptosis-related long non-coding RNA signature to predict the prognosis and immune microenvironment characterization for lung adenocarcinoma.
    Ma S; Zhu J; Wang M; Zhu J; Wang W; Xiong Y; Jiang R; Seetharamu N; AbrĂ£o FC; Puthamohan VM; Liu L; Jiang T
    Transl Lung Cancer Res; 2022 Oct; 11(10):2079-2093. PubMed ID: 36386454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular subtypes of lung adenocarcinoma patients for prognosis and therapeutic response prediction with machine learning on 13 programmed cell death patterns.
    Wei Q; Jiang X; Miao X; Zhang Y; Chen F; Zhang P
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11351-11368. PubMed ID: 37378675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cuproptosis-related lncRNAs risk model to predict prognosis and guide immunotherapy for lung adenocarcinoma.
    Li Q; Wang T; Zhu J; Zhang A; Wu A; Zhou Y; Shi J
    Ann Transl Med; 2023 Mar; 11(5):198. PubMed ID: 37007546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cuproptosis-related risk score predicts prognosis and characterizes the tumor microenvironment in colon adenocarcinoma.
    Wang J; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Qin D; Zhong S; Hu X
    Front Oncol; 2023; 13():1152681. PubMed ID: 37333810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular subtypes based on cuproptosis-related genes and immune profiles in lung adenocarcinoma.
    Wang Y; Zhang C; Ji C; Jin W; He X; Yu S; Guo R
    Front Genet; 2022; 13():1006938. PubMed ID: 36313439
    [No Abstract]   [Full Text] [Related]  

  • 10. Anoikis-related subtype and prognosis analyses based on bioinformatics, and an expression verification of ANGPTL4 based on experiments of lung adenocarcinoma.
    Shen X; Xie J; Liu S; Cai Y; Yuan S; Uehara Y; Zhu D; Zheng M
    J Thorac Dis; 2024 Aug; 16(8):5361-5378. PubMed ID: 39268091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel defined risk signature of cuproptosis-related long non-coding RNA for predicting prognosis, immune infiltration, and immunotherapy response in lung adenocarcinoma.
    Ma C; Li F; Gu Z; Yang Y; Qi Y
    Front Pharmacol; 2023; 14():1146840. PubMed ID: 37670938
    [No Abstract]   [Full Text] [Related]  

  • 12. Comprehensive analysis of the cuproptosis-related model to predict prognosis and indicate tumor immune infiltration in lung adenocarcinoma.
    Wu M; Bao J; Lei Y; Tao S; Lin Q; Chen L; Jin Y; Ding X; Yan Y; Han P
    Front Oncol; 2022; 12():935672. PubMed ID: 36338763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a cuproptosis-related signature for prognosis prediction in lung adenocarcinoma based on WGCNA.
    Ling X; Zhang L; Fang C; Liang H; Zhu J; Ma J
    Transl Lung Cancer Res; 2023 Apr; 12(4):754-769. PubMed ID: 37197625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic model for hepatocellular carcinoma based on anoikis-related genes: immune landscape analysis and prediction of drug sensitivity.
    Zhang D; Liu S; Wu Q; Ma Y; Zhou S; Liu Z; Sun W; Lu Z
    Front Med (Lausanne); 2023; 10():1232814. PubMed ID: 37502362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of a prognostic signature for lung adenocarcinoma using cuproptosis-related lncRNAs.
    Yalimaimaiti S; Liang X; Zhao H; Dou H; Liu W; Yang Y; Ning L
    BMC Bioinformatics; 2023 Mar; 24(1):81. PubMed ID: 36879187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel anoikis-related gene signature to predict the prognosis, immune infiltration, and therapeutic outcome of lung adenocarcinoma.
    Wang Y; Xie C; Su Y
    J Thorac Dis; 2023 Mar; 15(3):1335-1352. PubMed ID: 37065587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular subtypes based on cuproptosis-related genes and tumor microenvironment infiltration characteristics in pancreatic adenocarcinoma.
    Li J; Yin J; Li W; Wang H; Ni B
    Cancer Cell Int; 2023 Jan; 23(1):7. PubMed ID: 36647100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel anoikis-related gene signature predicts prognosis in patients with breast cancer and reveals immune infiltration.
    Tang C; Qin L; Li J
    Medicine (Baltimore); 2023 Oct; 102(43):e35732. PubMed ID: 37904416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cuproptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of early-stage lung adenocarcinoma patients.
    Tang Y; Li Q; Zhang D; Ma Z; Yang J; Cui Y; Zhang A
    Front Genet; 2022; 13():977156. PubMed ID: 36186452
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of cuproptosis and immune-related gene prognostic signature in lung adenocarcinoma.
    Zhang W; Qu H; Ma X; Li L; Wei Y; Wang Y; Zeng R; Nie Y; Zhang C; Yin K; Zhou F; Yang Z
    Front Immunol; 2023; 14():1179742. PubMed ID: 37622116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.